A Phase I Double-blinded, Placebo-controlled, Randomized Trial in HIV-uninfected, Healthy Adult Volunteers to Evaluate the Safety and Immunogenicity of an Adjuvanted GSK HIV Vaccine Administered With Ad35-GRIN Investigational Vaccine.
Phase of Trial: Phase I
Latest Information Update: 25 Oct 2015
At a glance
- Drugs AIDS vaccines
- Indications HIV infections
- Focus Adverse reactions; Pharmacodynamics
- 01 Nov 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Aug 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 07 Mar 2011 Actual initiation date (Feb 2011) added as reported by ClinicalTrials.gov.